Ogeda is a drug discovery business that developed Fezolinetant, a non-hormonal treatment for women's disorders such as hot flashes and uterine fibroids
Ogeda is a drug discovery business that developed Fezolinetant, a non-hormonal treatment for women's disorders such as hot flashes and uterine fibroids. The company was acquired by Astellas in 2017 after completing phase II studies.